Merck prepares for post-antibiotic era with Cubist purchase

Merck will spend $8.4 billion US to buy Cubist Pharmaceuticals and move deeper into treating so-called "superbugs" that have drawn dire warnings from global health organizations.

from CBC | Health News http://ift.tt/1yI5EbU